We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND For Clinical Trial With Targeted, Nano-Delivered RNAi Therapeutic For Cancer
Cancer / Oncology Arrowhead Research Corporation (NASDAQ:ARWR) announced that its majority owned subsidiary, Calando Pharmaceuticals, a leading siRNA therapeutics company, submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration to initiate a Phase I clinical trial using their lead anti-cancer compound, CALAA-01. "Calando's technology addresses a primary obstacle to the use of siRNA therapeutics: an effective delivery mechanism," said Dr.
Custom Search
